MedPath

Effect of Amino Acids and Sugar Alcohols on Satiation Peptides and Activation of Specific Brain Regions

Not Applicable
Completed
Conditions
Endocrine System Diseases
Interventions
Dietary Supplement: 1.56 g L-Leucine
Dietary Supplement: 50 g Xylitol
Dietary Supplement: 1.56 g L-Tryptophan
Dietary Supplement: 75 g Erythritol
Dietary Supplement: 75 g Glucose
Dietary Supplement: Tap water
Dietary Supplement: Mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate)
Device: Nasogastric Tube
Registration Number
NCT02823249
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

With this study the investigators investigate the effects of amino acids (tryptophan, leucin) and sugar alcohols (xylitol, erythritol) on satiety mechanisms and brain activation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Healthy normal weight subjects with a body-mass index of 19.0-24.9
  • Healthy obese subjects with a body-mass index of > 30
  • Normal eating habits (no diets; no dietary changes; no special dietary habits such as vegetarian/vegan)
  • Age 18-40 years
  • Stable body weight for at least three months
Exclusion Criteria
  • Smoking
  • Substance abuse
  • Regular intake of medications (except for oral contraceptives)
  • Medical or psychiatric illness
  • History of gastrointestinal disorders
  • Food allergies
  • Pregnancy, breast feeding
  • Body piercings that cannot be removed
  • History of claustrophobia
  • Left-hander

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1.56 g L-TryptophanTap water1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
1.56 g L-Leucine1.56 g L-Leucine1.56 g L-Leucine in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
75 g ErythritolTap water75 g Erythritol in 300 mL tap water given via nasogastric tube
50 g Xylitol50 g Xylitol50 g Xylitol in 300 mL tap water given via nasogastric tube
75 g Glucose and mixed liquid mealTap water75 g Glucose in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
1.56 g L-Tryptophan1.56 g L-Tryptophan1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
1.56 g L-TryptophanMixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate)1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
1.56 g L-TryptophanNasogastric Tube1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
75 g Erythritol75 g Erythritol75 g Erythritol in 300 mL tap water given via nasogastric tube
75 g Glucose and mixed liquid meal75 g Glucose75 g Glucose in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
1.56 g L-LeucineMixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate)1.56 g L-Leucine in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
50 g XylitolTap water50 g Xylitol in 300 mL tap water given via nasogastric tube
50 g XylitolNasogastric Tube50 g Xylitol in 300 mL tap water given via nasogastric tube
75 g Glucose and mixed liquid mealMixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate)75 g Glucose in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
Tap water and mixed liquid mealTap water300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
1.56 g L-LeucineTap water1.56 g L-Leucine in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
1.56 g L-LeucineNasogastric Tube1.56 g L-Leucine in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
75 g ErythritolNasogastric Tube75 g Erythritol in 300 mL tap water given via nasogastric tube
75 g Glucose and mixed liquid mealNasogastric Tube75 g Glucose in 300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
Tap water and mixed liquid mealMixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate)300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
Tap water and mixed liquid mealNasogastric Tube300 mL tap water given via nasogastric tube + after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube
Primary Outcome Measures
NameTimeMethod
Effect of sugar alcohols on cerebral blood flow measured by functional brain MRIchanges from baseline to one hour after treatment
Effect of aminoacids on cerebral blood flow measured by functional brain MRIchanges from baseline to one hour after treatment
Secondary Outcome Measures
NameTimeMethod
Measurement of Plasma cholecystokinin concentrationschanges from baseline to three hours after treatment
Measurement of Plasma Glucagon-like Peptide (GLP-1) concentrationschanges from baseline to three hours after treatment
Measurement of Plasma PYY concentrationschanges from baseline to three hours after treatment
Measurement of Plasma ghrelin concentrationschanges from baseline to three hours after treatment
Measurement of Plasma Glucose concentrationschanges from baseline to three hours after treatment
Measurement of Plasma Insulin concentrationschanges from baseline to three hours after treatment

Trial Locations

Locations (1)

University Hospital Basel

🇨🇭

Basel, Basel-Stadt, Switzerland

© Copyright 2025. All Rights Reserved by MedPath